cT1N0M0非小细胞肺癌中央位置几何测量预测N1而非N2分期上调
本研究回顾性纳入209例影像和代谢分期为T1N0M0的非小细胞肺癌患者,采用内缘比和外缘比几何测量肿瘤中央位置,cutoff分别为0.5和0.64。中央位置预测N1分期上调(校正OR 4.2,95%CI 1.5-12,P<.007),但不预测N2上调。
要点
- 内缘比0.5和外缘比0.64可用于定义中央型肿瘤。
- 中央位置预测N1分期上调,不预测N2分期上调。
- 该测量有助于筛选需要N0状态的治疗患者。
核心结论
- 基于内缘比和外缘比的中央肿瘤位置可预测影像和代谢T1N0M0患者的N1分期上调,但不预测N2分期上调。
研究设计与样本
- 回顾性研究纳入209例确诊非小细胞肺癌、影像和代谢分期为T1N0M0并接受有创纵隔分期和/或肺切除的患者。
主要发现
- N1和N2分期上调的患病率分别为11%和5.3%。
- 内缘比和外缘比的cutoff分别为0.5和0.64。
- 两比值均预测N1分期上调(校正OR 4.2,95%CI 1.5-12,P<.007,AUC 0.65),但不预测N2分期上调。
关键数值与推荐
- 内缘比cutoff为0.5,外缘比cutoff为0.64,低于cutoff视为中央型。
- N1分期上调患病率11%,N2分期上调患病率5.3%。
临床怎么用
- 对影像和代谢T1N0M0的非小细胞肺癌患者,可用内缘比和外缘比评估中央位置以预测N1分期上调风险。
- 该测量有助于筛选适合需要N0肿瘤的治疗方案的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In patients with non-small cell lung cancer (NSCLC) and normal mediastinum, the central tumor location predicts occult nodal disease (both N1 and N2). We evaluated a novel definition of central location based on a geometrical measurement of the tumor location within the lung that could predict N2, N1, or both. METHODS: This retrospective study included patients with confirmed NSCLC, radiologically and metabolically staged T1 N0 M0, who underwent invasive mediastinal staging and/or lung resection. The central tumor location was measured considering 2 ratios. The inner margin ratio (IMR) and outer margin ratio (OMR) were both calculated as the distance from the inner margin of the lung to both margins of the tumor (inner [IMR], outer [OMR]) divided by the lung width. Optimal cutoffs for IMR and OMR were calculated. Tumors with values lower than the cutoffs were considered central. Prevalences of N1 and N2 upstaging were estimated and bivariate logistic regression analysis was performed to predict the odds of N1 and N2 upstaging using IMR and OMR cutoffs. RESULTS: A total of 209 patients were included. The prevalence of N1 and N2 upstaging was 11% and 5.3%, respectively. Cutoffs of 0.5 for IMR and 0.64 for OMR were estimated. Both ratios predicted N1 upstaging (adjusted odds ratio [95% confidence interval]: 4.2 [1.5-12]; P < .007; area under the curve, 0.65) but did not predict N2 upstaging. CONCLUSIONS: Central tumor location can be assessed by means of IMR and OMR and predicts N1 upstaging in patients with radiologically and metabolically T1 N0 M0 tumors. This is important for the selection of patients for therapies that require N0 tumors.
引用
- Sanz-Santos J, Martínez-Palau M, Jaen À, et al. Geometrical Measurement of Central Tumor Location in cT1N0M0 NSCLC Predicts N1 but Not N2 Upstaging. Ann Thorac Surg. 2020. PMID: 32853568. doi:10.1016/j.athoracsur.2020.06.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。